Respiratory disease in rhesus macaques inoculated with SARS-CoV-2

被引:0
作者
Vincent J. Munster
Friederike Feldmann
Brandi N. Williamson
Neeltje van Doremalen
Lizzette Pérez-Pérez
Jonathan Schulz
Kimberly Meade-White
Atsushi Okumura
Julie Callison
Beniah Brumbaugh
Victoria A. Avanzato
Rebecca Rosenke
Patrick W. Hanley
Greg Saturday
Dana Scott
Elizabeth R. Fischer
Emmie de Wit
机构
[1] National Institutes of Health,Laboratory of Virology, National Institute of Allergy and Infectious Diseases
[2] National Institutes of Health,Rocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases
[3] National Institutes of Health,Research Technologies Branch, National Institute of Allergy and Infectious Diseases
来源
Nature | 2020年 / 585卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
An outbreak of coronavirus disease 2019 (COVID-19), which is caused by a novel coronavirus (named SARS-CoV-2) and has a case fatality rate of approximately 2%, started in Wuhan (China) in December 20191,2. Following an unprecedented global spread3, the World Health Organization declared COVID-19 a pandemic on 11 March 2020. Although data on COVID-19 in humans are emerging at a steady pace, some aspects of the pathogenesis of SARS-CoV-2 can be studied in detail only in animal models, in which repeated sampling and tissue collection is possible. Here we show that SARS-CoV-2 causes a respiratory disease in rhesus macaques that lasts between 8 and 16 days. Pulmonary infiltrates, which are a hallmark of COVID-19 in humans, were visible in lung radiographs. We detected high viral loads in swabs from the nose and throat of all of the macaques, as well as in bronchoalveolar lavages; in one macaque, we observed prolonged rectal shedding. Together, the rhesus macaque recapitulates the moderate disease that has been observed in the majority of human cases of COVID-19. The establishment of the rhesus macaque as a model of COVID-19 will increase our understanding of the pathogenesis of this disease, and aid in the development and testing of medical countermeasures.
引用
收藏
页码:268 / 272
页数:4
相关论文
共 32 条
[1]  
Wu F(2020)A new coronavirus associated with human respiratory disease in China Nature 579 265-269
[2]  
Zhu N(2020)A novel coronavirus from patients with pneumonia in China, 2019 N. Engl. J. Med. 382 727-733
[3]  
Yang W(2020)Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China J. Infect. 80 388-393
[4]  
Yang X(2020)Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Lancet Respir. Med. 8 475-481
[5]  
Silverstein WK(2020)First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia Lancet 395 734-1062
[6]  
Stroud L(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 395 1054-1720
[7]  
Cleghorn GE(2020)Clinical characteristics of coronavirus disease 2019 in China N. Engl. J. Med. 382 1708-434
[8]  
Leis JA(2020)Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Lancet Infect. Dis. 20 425-1179
[9]  
Zhou F(2020)SARS-CoV-2 viral load in upper respiratory specimens of infected patients N. Engl. J. Med. 382 1177-1339
[10]  
Guan WJ(2020)Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea J. Korean Med. Sci. 35 e86-1273